Wall Street was back on shaky ground on Tuesday (March 27), with huge declines in technology shares leaving major stock indices sharply lower. Let's dig deeper into whether Walgreens Boots Alliance should have a place in your portfolio. Finally, Burgundy Asset Management Ltd. raised its position in Walgreens Boots Alliance by 0.4% during the 4th quarter. Edmond DE Rothschild Holding S.A. now owns 6,700 shares of the pharmacy operator's stock worth $524,000 after acquiring an additional 235 shares during the last quarter. Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance in a research report on Monday, December 4th. They set an "equal weight" rating and a $76.00 price objective for the company. Finally, Loop Capital set a $90.00 target price on shares of Walgreens Boots Alliance and gave the stock a "buy" rating in a research report on Wednesday, January 3rd. Needham & Company LLC cut their price target on Walgreens Boots Alliance to $86.00 and set a "buy" rating on the stock in a report on Wednesday, November 22nd. ValuEngine downgraded shares of Walgreens Boots Alliance from a "buy" rating to a "hold" rating in a research report on Friday, February 2nd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. Walgreens Boots Alliance now has an average rating of "Buy" and an average price target of $84.45. Investors may be tracking this ratio in order to gauge the amount of profit that the company generates as a percentage of the value of its total assets. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Stocks Pen (SP) makes sure to keep the information up to date and correct, but we didn't suggest or recommend buying or selling of any financial instrument, unless that information is subsequently confirmed on your own. The stock appeared $87.79 above its 52-week highs and is up 1.28% for the last five trades. A total of 7,981,040 shares exchanged hands during the intra-day trade contrast with its average trading volume of 5.62M shares, while its relative volume stands at 1.31. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. A beta of greater than 1 indicates that the security's price is theoretically more volatile than the market.
Valuations and Returns for Walgreens Boots Alliance, Inc. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.27 by $0.01.
The ratios of the return on assets (ROA) and the return on owner's equity (ROE) are the most used profitability ratios in the analysis while ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business. The company had revenue of $33.02 billion during the quarter, compared to analyst estimates of $32.20 billion. The company has a market cap of $66,840.44, a price-to-earnings ratio of 18.65, a P/E/G ratio of 1.11 and a beta of 1.21. Walgreens Boots Alliance's quarterly revenue was up 7.9% compared to the same quarter a year ago.
Monmouth County sheriff cracks down on distracted driving
Michigan State Police say distracted driving is believed to be the cause of a crash that killed a 6-year-old girl last week. Unlike adult drivers, drivers under the age of 18 are considered novice drivers and can't use hands-free cell phones.
The business also recently announced a quarterly dividend, which was paid on Monday, March 12th. Investors of record on Thursday, February 15th were issued a dividend of $0.40 per share. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell. Walgreens Boots Alliance's dividend payout ratio is now 44.20%.
TRADEMARK VIOLATION NOTICE: This story was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another publication, it was copied illegally and republished in violation of USA & worldwide copyright and trademark laws.